IL-24 serum concentrations and the interval from symptom onset to blood collection were compared between hospitalized COVID-19 patients (including critical, severe, and moderate disease courses) at the time of their first blood draw after hospital admission or inpatient transfer (H1), and outpatients after a mild disease course during convalescence (O1). This evidence concerns the gene IL24 and COVID-19.